Pharmacopeia dengue double talk – Paving the way for patent vaccines and drugs

First let’s make something very perfectly clear, a simple cure for dengue fever has been known since 2008. In 2011, Dr. Sanath Hettige wrote a second paper to the British Medical Journal referencing his findings in 2008. Someone with the proper knowledge, should research how many needless deaths, especially of innocent children have passed between 2008-2011, because of the foot-dragging response given to this simple cure.

Four years passing, 2012, news media is starting to recognize papaya extract as a low-cost speedy cure for dengue fever. What are the benefits of Dr. Hettige findings:

  • Very affordable, almost free, to all regardless of income or the lack thereof
  • Vital organ damage healing begins
  • Stop excessive bleeding of DHF (a life saving benefit)
  • No hospitalization required– when diagnosed in the early stages
  • No known or anticipated side effects
  • Almost anyone can prepare the papaya juice with little coaching

Now let’s attempt to understand why this cure has not circled the globe by dissecting an article published by Poon Chian Hui, Asia News Network

Let us open our minds and see if we come to an agreement– the pathway for patent drugs and vaccines have been in the works for some time. The 2012 article below serves as a prime example of what I’m asking you to consider. If you want to read the article first just click the article link below.

Discovery raises hopes of cure for dengue fever

– Poon Chian Hui, Asia News Network (The Straits Times), Singapore | Health | Fri, June 22 2012, 1:20 PM A- A A+

  • The headline and link is disingenuous because an affordable speedy cure already exists, and this headline is represents only type DENV1. Hope means in years to come.

Scientists in Singapore have uncovered a powerful antibody that can stifle and kill the dengue virus in two hours, in a finding that opens the door to a cure for the mosquito-borne infection.

  • It kills the virus in two hours– but no details given about platelets, white blood cells, liver and other vital health complications

Currently, there are no drugs or vaccines on the market that can counter dengue fever.

But this newly identified antibody, which is naturally present in humans, has been shown in mice to destroy the virus at a much faster rate than other dengue-fighting compounds around.

  • no drugs or vaccines”– true, there are no other drugs or vaccines ( a door opener for the drug and vaccine industry
  • newly identified antibody, …have been shown in mice to destroy the virus, …much faster than other dengue-fighting compounds around”– this refutes what they just stated “there are no drugs or vaccines on the market that can counter dengue fever.”

It appears to be effective against subtype 1 of the virus DENV1, which accounts for up to half of dengue cases in Singapore.

  • effective against subtype 1 of the virus DENV1”– three types not in their ‘appears’ analogy so that also leaves out the most dangerous DHF.

The landmark findings were published on Thursday in international journal Science Translational Medicine. The study was carried out by scientists from the National University of Singapore’s Yong Loo Lin School of Medicine, Duke-NUS Graduate Medical School and the Defense Medical & Environmental Research Institute at DSO National Laboratories.

  • It will pay for someone to clue us in on the associations of each of the institutions mentioned above. So we can determine whose interest they are noted for serving, patients or patent dealing drug and vaccine industrialist.

Over two years, the team studied groups of cells extracted from about 200 patients who had recovered from dengue fever after being treated at Tan Tock Seng Hospital. They pinpointed an antibody that can stick to the virus, and lock it down so it does not attack other cells.

  • They pinpointed an antibody that can stick to the virus”,– pin pointing and extracting cells, you can hear the rush to the patent office loud and clear
  • Someone is going to have to reimburse for all this scientific testing and lab studies

Principal investigator Paul Macary from the university’s medical school said the antibody leads to a 50,000-fold reduction of the virus in two hours. It also work in very small amounts.

  • 50,000-fold reduction of the virus in two hours.– commendable but nothing said about the recovery of the bodies vital organs if they were affected before getting this treatment

‘Essentially this means that this antibody is a million times better than any small molecule compounds that had ever been made for dengue,’ said Associate Professor Macary, who is from the microbiology department.

  • a million times better than any small molecule compounds that had ever been made for dengue”,– of which they said there were none

He said that the antibody will be produced when a person gets infected, ‘but the scale of the response is too small for it to have an impact on the infection’.

By injecting a larger amount of it into the patient, however, the recovery can be accelerated.

Side effects are likely to be minimal as the compound is already present in the body, he added.

  • Side effects are likely to be minimal”– summing up the above three paragraphs you get the usual protective-shell of mindless pharmacopoeia. They have no clue what will happen extracting live antibodies out of diseased bodies. How many times are we to go down this road.

There have been some 1,700 cases of dengue so far this year, according to the latest figures from the Ministry of Health.

In all, Singapore receives about 5,000 cases annually. During epidemics, the number can go as high as 15,000 cases a year.

Globally, the World Health Organization estimates that there are 50 million to 100 million dengue infections every year.

Dengue patients usually become ill within a week of being bitten by an infected mosquito.

It takes about two weeks for patients to recover. But some go on to develop dengue haemorrhagic fever, which can kill.

Associate Professor Leo Yee Sin, clinical director of the Communicable Disease Centre at Tan Tock Seng Hospital, said treatment for dengue ‘has been stagnant for many years’.

At hospitals, patients are monitored and given supportive treatment. For example, they will be put on drips to provide them with fluids, or receive blood platelets.

‘This has been the traditional way of treating dengue for many decades – we let the body fight the infection on its own,’ said Prof Leo.

The research team will be starting clinical trials in the next year or so, and a therapy is expected to be available within the next six to eight years.

Developing a vaccine may be next on the list. The team also hopes to uncover antibodies for the other dengue subtypes within the next two years.

  • I have no words to say about the above paragraphs except there is a cure now! How many people will fall sick, how many will die, while a mindless industry ignores papaya-leaf-juice-helps-cures-dengue-fever and repairs other vital organs when taken before a patient reaches the final stage.  Drug companies are only interested in finding something to patent and in the mean time dengue is getting the upper hand when and where it strikes.

Your comments and questions are welcomed!

Advocating the findings of Doctor Sanath Hettige

About PLXC-CTC Dengue Remedies

Let the sunshine in,/Nicasio Martineznm

Truth is a gem you have to search out, deeply and far beyond readily available institutions that assail your ears, eyes, thoughts, feelings, and emotions.

Disclaimer: As a Great-grandfather family webmaster, what I share should never be accepted as being medical advice, merely a sharing of easily researchable links for the purpose of educational sharing in the public interest.

You should research for yourself and make your best intelligent decisions— even before or after consulting with medical professionals who have earned your trust. /Nicasio Martinez